Aortyx SL secured €13.8 million (US$15.9 million) in a series A funding round for its solution which treats aortic dissection. The company developed a system to repair the aortic tear, which includes ...

Spanish company Aortyx has secured €13.8m ($15.8m) in a Series A financing round to further develop its bioresorbable patch, ...

Aortyx announced today that it brought in $16 million (€13.8 million) to support its bioresorbable aortic patch technology.

Elizabeth: Trends in cervical artery dissection and recurrent stroke in the United States. Rick: Preventing venous thrombosis -- or clotting -- in people with cancer. Elizabeth: USPSTF on ...

Objective We retrospectively analysed outcome data from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study to assess the incidence and potential risk factors of sudden cardiac death (SCD) ...

In the acute and subacute stage, MRA detected signal abnormalities within the dissected vertebral artery in 94% (16/17) and MRI was specific for a dissection in 29% (5/ ... segments of the vertebral ...